Salesforce (CRM)
Software / Servicios de aplicaciones
The leader in customer relationship management (CRM) software, punished to 52-week lows (~$206) by fear of AI disruption and confusion over its reported growth. Net of stock-based compensation and the ASR debt, it trades at ~18× owner-FCF — the cheap end of quality software. Base case 5y ~$289 (+8%/year): Fairly valued — the moat (switching costs + a $72bn contracted backlog) and the compounding cash flow are undervalued, even though the new leverage and the AI threat are real.
- Price
- $206.21
- Intrinsic value (5y, base)
- $289
- Total annual return (5y)
- 7.9%
- Status (nominal)
- Fairly valued
- Margin of safety
- +15%
The essentials
- The undisputed leader in customer relationship management (CRM) software: revenue $42.8bn, 95% recurring subscription, with a contracted backlog (RPO) of $72.4bn (+14%) and a cRPO accelerating faster than revenue. Margins expanding sharply (GAAP operating margin 3.3%→20.1% over 4 years, non-GAAP 22.5%→34.1%) with ValueAct's activism pushing the discipline.
- Trades at 52-week lows (~34% below the peak), the cheapest of the software group (~12× forward P/E vs NOW 24× / SAP 20×) — the market treats it as a mature, no-growth SaaS, punished by fear that AI will cannibalize seats and by confusion over its reported growth (two product taxonomy redesigns in 6 months + the noise from Informatica).
- ⚠️ The capital structure changed abruptly: in March 2026 it issued $25bn of debt to fund an accelerated share repurchase (ASR) — shares fell from ~923M to ~819M in one quarter, but debt jumped to $39.3bn (net debt ~$27.4bn) and cash flow guidance was cut for the interest cost. The 'cheap ~9.7× P/FCF' is doubly misleading: FCF adds back stock-based compensation (~24% of the flow) and the price ignores net debt. The real metric, EV/owner-FCF net of both, is ~18×.
Intrinsic value — two valuation methods
Total return at 5 years: 7.9%/year = 7.0% appreciation + 0.9% dividend. The target price ($289) is ex-dividend; the $11 in dividends collected over 5 years are added separately.
By both methods, the value today (DCF $393 · Multiples $241) exceeds the market price ($206).
Pillars of the analysis
The verdict — today vs 5 years
Today — fairly valued: at $206 trades ~14.5% below its value discounted to today (~$241); the discount is positive but does not reach the margin of safety we require (≥38%).
At 5 years — En valor: the target price ($289) plus dividends yield between the 4% floor and the 10% average return — a reasonable return, though without the margin of a great investment.
The bridge: the return at 5 years exceeds the risk-free rate (4.5%) — but the discount does not reach the required margin of safety (≥38%). To require a 15% annual return, it would need to be bought at ~$151.
Thesis
The business
Salesforce is the leader in customer relationship management software, a recurring-subscription business (95% of revenue) with a wide switching-cost moat, sharply expanding margins (non-GAAP operating margin 22.5%→34.1% over 4 years, with ValueAct's activism pushing the discipline) and a $72.4bn contracted backlog that anticipates revenue. It is a quality SaaS: capital-light, large and predictable cash flow, high stickiness. The open question is the direction of the moat in the face of AI.
The valuation
A quality SaaS is valued on EV/owner-FCF net of stock-based compensation (§3: reported cash flow adds that cost back, ~24% of the flow — it must be expensed). TTM owner-FCF is ~$11.1bn (free cash flow $14.7bn − stock-based compensation $3.6bn). With the ASR net debt (~$27.4bn) in the bridge, EV/owner-FCF is ~18× — the cheap end of quality software (the band is 14-20×), and the cheapest of the peer group (~12× forward P/E vs NOW 24× / SAP 20×). The '~9.7× P/FCF' shown by aggregators is doubly misleading: it adds back stock-based compensation and the price ignores net debt.
The base scenario projects owner-FCF growing ~8%/year (revenue ~8% organic + margin expansion) from ~$11bn to ~$16.4bn over five years, at an exit multiple of 15× (no re-rating — it is already at a depressed multiple). With the buyback reducing shares ~1.5%/year, that yields ~$289/share → a total return of +8%/year. Leverage amplifies: as the flow grows, equity grows faster than enterprise value.
The margin of safety
It trades close to intrinsic value, far from the required margin of safety. At ~$206, near 52-week lows, the market is paying for Salesforce as if it were a mature, no-growth SaaS doomed by AI. The base scenario ($289/share over five years) implies a total return of +8%/year — above the required return floor: the verdict is Fairly valued. The discrepancy between perception and reality is the source of the opportunity: the moat (switching costs + a $72bn contracted backlog) and the compounding cash flow are undervalued because reported growth looks confusing (two taxonomy redesigns in 6 months + the noise from Informatica) and because the fear of AI disruption is fully priced in. The risk is real and defines the adverse scenario: if AI cannibalizes seats and organic growth stalls, with the new leverage the value falls below the price. It is an asymmetry with wide upside and a bounded — but material — downside.
What to watch
Three things. AI disruption: if Agentforce monetizes agent work (its ARR already crossed $1.2bn, +205%) and offsets the pressure on seats, the thesis is confirmed; if seats erode without AI consumption replacing them, the moat narrows — this is the central disconfirmer. Organic reacceleration: the company guides for it in the second half of FY27; if reported growth keeps leaning on Informatica (~3pp) without the organic figure picking up, the quality of growth disappoints. And the balance sheet: the new leverage ($39bn of debt) cut the flow guidance — watch that deleveraging and the buyback don't compete with reinvestment. If organic growth stabilizes and Agentforce scales, the current discount closes; if AI bites into seats before Agentforce offsets it, the leverage hurts.
Educational / informational. Does not constitute investment advice.